At2g34300 Antibody

What is At2g34300 and what does the antibody detect?

At2g34300 is a gene in Arabidopsis thaliana (Mouse-ear cress) that encodes a probable methyltransferase called PMT25, which belongs to the S-adenosyl-L-methionine-dependent methyltransferases superfamily protein . The At2g34300 antibody specifically detects this protein in experimental applications. Research indicates that At2g34300 is homologous to QUASIMODO 3 (QUA3), which belongs to a unique branch in the QUA3 family protein classification . The antibody detects the native protein in membrane protein fractions, particularly from Arabidopsis suspension-cultured cells where expression levels are significantly higher compared to intact seedlings .

What are the validated applications for the At2g34300 antibody?

The At2g34300 antibody has been validated for several research applications:

• Western Blot (WB): Effective for detecting the protein in membrane fractions and determining relative expression levels across different tissues and experimental conditions

• ELISA (Enzyme-Linked Immunosorbent Assay): Suitable for quantitative detection of the target protein

• Immunofluorescence: Can be used for subcellular localization studies, particularly in fixed cells

• Immunogold Electron Microscopy (EM): Validated for high-resolution localization studies, demonstrating specificity for Golgi apparatus labeling

What is the specificity and cross-reactivity profile of the At2g34300 antibody?

The At2g34300 antibody demonstrates high specificity for its target protein. In studies with Arabidopsis suspension cells, the antibody specifically detects QUA3 in membrane protein fractions with minimal background labeling of other organelles . Immunogold EM analysis confirmed this specificity, showing preferential labeling of the Golgi apparatus with little labeling observed in other organelles . The antibody was generated against a synthetic peptide located between the transmembrane domain (TMD) and the DUF248 domain (sequence: CEDPRRNSQLSREMNFYR), which likely contributes to its specificity . Researchers should note that while the antibody shows high specificity in Arabidopsis, cross-reactivity testing in other plant species would be necessary for broader applications.

What are the optimal protocols for Western blot using At2g34300 antibody?

For optimal Western blot results with the At2g34300 antibody, researchers should follow these methodological considerations:

• Sample preparation:

  • Use membrane protein fractions rather than total protein extracts for higher sensitivity

  • Equal protein loading should be quantified using both Coomassie blue staining and detection with established markers like anti-Man1 (Golgi marker)

• Antibody concentration:

  • Use affinity-purified antibody at a concentration of 4 μg/ml

• Detection system:

  • Use appropriate secondary antibodies such as anti-rabbit IgG conjugated with suitable detection systems

• Controls:

  • Include positive controls (protein extracts from suspension-cultured cells)

  • Include negative controls (non-expressing tissues or knockout lines if available)

  • Consider using comparative detection with other organelle markers (Man1, VSR, Sec23p, Sar1p) to confirm specificity

How should I optimize immunolocalization studies with At2g34300 antibody?

For successful immunolocalization of At2g34300/PMT25:

• Fixation methods:

  • For fluorescence microscopy: Chemical fixation methods have been successfully employed for co-localization studies

  • For electron microscopy: High-pressure freezing/freeze substitution of cells provides superior ultrastructural preservation for immunogold labeling

• Co-localization markers:

  • Use established Golgi markers (e.g., anti-Man1 or Man1-mRFP fusion protein)

  • Distinguish from other organelles using markers like anti-VSR (PVC marker), anti-AtSec23 (COPII marker), and anti-AtSar1 (COPI marker)

• Treatment considerations:

  • Wortmannin treatment (an inhibitor of phosphatidylinositol 3-kinase) can be used as a control to distinguish Golgi from PVC, as it induces dilation of plant PVCs without affecting Golgi morphology

How does the expression of At2g34300 vary across different experimental systems?

Research demonstrates significant variation in At2g34300 expression across different experimental systems:

This expression pattern is unique among the 29 Arabidopsis QUA3 homologues, with most other homologues showing higher expression in seedlings than in suspension cultures . This suggests a specific regulatory role for At2g34300/PMT25 in suspension-cultured cells, particularly in relation to pectin methylation .

How can I confirm the enzymatic activity of At2g34300/PMT25?

To evaluate the enzymatic activity of At2g34300/PMT25 as a methyltransferase:

• Activity assay setup:

  • Use methyl group transfer assays with radiolabeled SAM (S-adenosyl-L-methionine)

  • Include homogalacturonan (HG) as a substrate to test specific methyltransferase activity

• Quantification methods:

  • Ensure equal protein loading through Coomassie blue staining and Western blot detection with Golgi markers

  • Compare activity between wild-type and overexpression lines to establish correlation between protein levels and enzymatic activity

• Functional validation considerations:

  • Consider the impact of protein fusion tags on enzymatic activity. Research has shown that C-terminal GFP fusion abolishes the enzymatic activity of QUA3 while maintaining correct localization

  • In transgenic systems, confirm both protein expression and enzymatic activity to ensure functional protein production

What approaches can distinguish At2g34300/PMT25 from other methyltransferase family members?

For distinguishing At2g34300/PMT25 from related methyltransferases:

• Phylogenetic analysis:

  • Arabidopsis QUA3 family proteins can be classified into three clusters (I, II, and III), with QUA3 belonging to a unique branch outside clusters I and II

  • Conducting comparative sequence analysis can help identify the unique features of At2g34300

• Expression profiling:

  • Quantitative RT-PCR analysis of the 29 Arabidopsis QUA3 homologues reveals distinctive expression patterns

  • At2g34300, along with At4g00750 and a few others, shows significantly higher expression in suspension cultures compared to seedlings, unlike most family members

• Functional analysis:

  • Different methyltransferases often have distinct substrate preferences and biological functions

  • Compare enzymatic activities using different potential substrates to determine specificity

What are common issues when using At2g34300 antibody and how can I address them?

When working with At2g34300 antibody, researchers may encounter these challenges:

• Low signal intensity in plant tissues:

  • This may reflect the naturally low expression of At2g34300 in intact plant tissues compared to suspension cultures

  • Solution: Consider using suspension-cultured cells where expression is higher, or use overexpression lines

• Non-specific binding:

  • While the antibody shows high specificity, optimization may be needed for different experimental systems

  • Solution: Increase antibody dilution, optimize blocking conditions, and include appropriate controls

• Variability in detection across sample types:

  • Expression varies significantly between suspension cultures and intact plants

  • Solution: Include positive controls (suspension culture extracts) and adjust exposure/development times accordingly

How can I validate the specificity of the At2g34300 antibody in my experimental system?

To comprehensively validate antibody specificity:

• Genetic validation:

  • Use RNA interference lines (e.g., qua3i) where the target protein expression is reduced

  • Compare wild-type and overexpression lines to confirm correlation between protein levels and signal intensity

• Biochemical validation:

  • Perform peptide competition assays with the immunizing peptide (CEDPRRNSQLSREMNFYR)

  • Use subcellular fractionation to confirm enrichment in expected fractions (Golgi/membrane fractions)

• Cross-validation with fluorescent protein fusions:

  • In systems with QUA3-GFP expression, co-localization of antibody signal with GFP confirms specificity

  • This approach has successfully demonstrated antibody specificity in transgenic tobacco BY-2 cells

How might computational approaches contribute to antibody design against At2g34300/PMT25?

Recent advances in computational antibody design could enhance research tools for studying At2g34300:

• De novo design strategies:

  • Computational tools like OptMAVEn-2.0 could be employed to design high-affinity antibody variable regions targeting specific epitopes of At2g34300

  • This approach could generate antibodies with optimized binding properties for different applications

• Affinity maturation simulation:

  • In silico affinity maturation, similar to approaches used in other antibody development projects, could improve binding characteristics

  • Computational maturation has shown average improvements of ~14 kcal/mol in binding energy in other antibody designs

• Epitope optimization:

  • Computational analysis could identify the most accessible and unique epitopes on At2g34300

  • This could reduce cross-reactivity with the 29 homologues in Arabidopsis

How can post-translational modifications affect At2g34300 antibody binding and function?

Understanding post-translational modifications (PTMs) is crucial for antibody research:

• Potential PTMs affecting antibody recognition:

  • As a methyltransferase, At2g34300 may undergo regulatory PTMs that could affect epitope accessibility

  • Researchers should consider the potential impact of phosphorylation, glycosylation, or other modifications on antibody binding

• Effect of core fucosylation on antibody function:

  • While not directly studied for At2g34300 antibodies, research on other antibodies shows that Fc core fucosylation significantly affects binding to Fc receptors and functional properties

  • This may be relevant when developing new antibody tools or when using secondary antibodies in detection systems

• Methodological considerations:

  • When studying potential PTMs, researchers should consider using phosphatase inhibitors, deglycosylation enzymes, or other modification-preserving protocols during sample preparation